|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Gilead Sciences (NASDAQ: GILD) through any online brokerage.
The latest price target for Gilead Sciences (NASDAQ: GILD) was reported by Argus Research on January 28, 2022. The analyst firm set a price target for 75.00 expecting GILD to rise to within 12 months (a possible 8.92% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Gilead Sciences (NASDAQ: GILD) is $68.86 last updated Fri Jan 28 2022 21:00:04 GMT+0000 (Coordinated Universal Time).
A quarterly cash dividend of $0.04 per share of Class A Common Stock. The quarterly cash dividend was payable on December 30, 2021 to stockholders of record on December 14, 2021.
Gilead Sciences’s $Q1 earnings are confirmed for after-market on April 28, 2022.
There is no upcoming split for Gilead Sciences.
Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.